Cite

HARVARD Citation

    Lu, C. et al. (2022). A Six-Gene Risk Model Based on the Immune Score Reveals Prognosis in Intermediate-Risk Acute Myeloid Leukemia. BioMed research international. p. . [Online]. 
  
Back to record